LIUS Inhibits the Expression of a List of Inflammation-Related Cell Death Regulators, Potentially via Transcription Factors TP53-, and SRF-Mediated Pathways in Cancer Cells and Non-cancer Cells Respectively. The gene discussed is TP53; the disease is cancer.